Rose Calixte
Psychiatric/Mental Health · Lake Worth, FLNPI 1750851861
Payments from drug & device makers
Across 451 payments — averaging $22.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$2K
- AbbVie$2K
- Otsuka America Pharmaceutical, Inc.$1K
- Neurocrine Biosciences, Inc.$821
- Alkermes, Inc.$725
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$694
- plus $3K from 20 others
What the payments were for
- Food & beverage$10,11399%
- Education$811%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 49 | $1,770 |
| AbbVie | 82 | $1,600 |
| Otsuka America Pharmaceutical, Inc. | 38 | $1,111 |
| Neurocrine Biosciences, Inc. | 45 | $821 |
| Alkermes, Inc. | 33 | $725 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 36 | $694 |
| Teva Pharmaceuticals USA, Inc. | 21 | $561 |
| Takeda Pharmaceuticals U.S.A., Inc. | 32 | $504 |
| Axsome Therapeutics, Inc. | 11 | $370 |
| Lundbeck LLC | 19 | $352 |
| Corium, LLC | 12 | $276 |
| E.r. Squibb & Sons, L.L.C. | 9 | $224 |
| Sunovion Pharmaceuticals Inc. | 16 | $212 |
| Vanda Pharmaceuticals Inc. | 8 | $183 |
| Idorsia Pharmaceuticals US Inc | 9 | $176 |
| Almatica Pharma LLC | 5 | $124 |
| Adlon Therapeutics L.p. | 6 | $116 |
| Tris Pharma Inc | 5 | $104 |
| Supernus Pharmaceuticals, Inc. | 4 | $73 |
| Ironshore Pharmaceuticals Inc. | 3 | $63 |
| Eisai Inc. | 2 | $35 |
| Currax Pharmaceuticals LLC | 2 | $25 |
| Noven Therapeutics, LLC | 1 | $23 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| Livanova USA, Inc. | 1 | $19 |
| Merck | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INVEGA SUSTENNA$584
- REXULTI$456
- INVEGA TRINZA$150
- CAPLYTA$128
- AUSTEDO$125
- Auvelity$119
- SPRAVATO$109
- VRAYLAR$100
How this compares
$10,194 in reported general payments places this provider in the 95th percentile of 3,096 psychiatric/mental health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AustedoDeutetrabenazine | 23 | $163,760 |
| IngrezzaValbenazine Tosylate | 13 | $102,303 |
| RexultiBrexpiprazole | 38 | $81,157 |
| VraylarCariprazine Hcl | 54 | $78,658 |
| TrintellixVortioxetine Hydrobromide | 28 | $16,033 |
| Aripiprazole | 100 | $11,349 |
| Lurasidone Hcl | 60 | $8,392 |
| Bupropion XlBupropion Hcl | 332 | $7,049 |
| BelsomraSuvorexant | 12 | $6,737 |
| RisperdalRisperidone | 14 | $5,836 |
| Trazodone Hcl | 237 | $5,053 |
| Duloxetine Hcl | 218 | $4,739 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 71 | $4,245 |
| Quetiapine Fumarate | 287 | $4,112 |
| Buspirone Hcl | 167 | $3,891 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo | $561 | $163,76023 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $821 | $102,30313 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $1,111 | $81,15738 claims |
| AbbVieVraylar | $1,600 | $78,65854 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $504 | $16,03328 claims |
| MerckBelsomra | $15 | $6,73712 claims |
| Johnson & JohnsonRisperdal | $1,770 | $5,83614 claims |
| Almatica Pharma LLCSertraline Hcl | $124 | $711121 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,096 psychiatric/mental health providers in Florida.
Other psychiatric/mental health in Lake Worth
- Roger RiveraKissimmee$1.6M
- Bethanie Simmons BecilJacksonville$782K
- Hannah PhillipsMaitland$455K
- Cheedy JajaTampa$266K
- Scott DurrancePensacola$224K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
- Angela DavenportAlachua$83K
- Natalie MoodyWinter Haven$75K
- Kelli BridgmanNew Smyrna Beach$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.